Intellectual Property India Publishes Patent Application for 'Linker Drug, And Preparation Method And Use Of Antibody-Drug Conjugate Thereof' Filed by Lepu Biopharma Co. Ltd.

MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517080407 A) filed by Lepu Biopharma Co. Ltd., Shanghai, on Aug. 25, for 'linker drug, and preparation method and use of antibody-drug conjugate thereof.'

Inventor(s) include Li, Hongfeng; Liu, Wei; Ma, Tian; Liu, Wenchao; Wu, Xiangyu; Wang, Yanchun; Xu, Zhenyi; Hu, Chaohong; and Qin, Minmin.

The application for the patent was published on Sept. 12, under issue no. 37/2025.

According to the abstract released by the Intellectual Property India: "A linker-drug conjugate, an antibody-drug conjugate, and a preparation method therefor and the use thereof. The linker-drug conjugate has a structure as shown in formula I, i.e., M-X-D (formula I), wherei...